Amitai I - Search Results

1

Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.

Kugler E, Cohen I, Amitai I, Ram R, Frisch A, Nachmias B, Canaani J, Moshe Y, Krayem B, Aumann S, Henig I, Vainstein V, Shargian L, Ganzel C, Yeshurun M, Levi I, Raanani P, Akria L, Ofran Y, Shimony S, Wolach O. Kugler E, et al. Among authors: amitai i. Br J Haematol. 2024 Sep;205(3):932-941. doi: 10.1111/bjh.19548. Epub 2024 May 23. Br J Haematol. 2024. PMID: 38782575

2

Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead.

Amitai I, Leader A, Raanani P. Amitai I, et al. Acta Haematol. 2016;136(1):43-4. doi: 10.1159/000445674. Epub 2016 May 10. Acta Haematol. 2016. PMID: 27160309 No abstract available.

3

Bone mineral density utilization in patients with newly diagnosed multiple myeloma.

Muchtar E, Dagan A, Robenshtok E, Shochat T, Oniashvili N, Amitai I, Raanani P, Magen H. Muchtar E, et al. Among authors: amitai i. Hematol Oncol. 2017 Dec;35(4):703-710. doi: 10.1002/hon.2303. Epub 2016 Jun 21. Hematol Oncol. 2017. PMID: 27329574

4

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.

Wolach O, Amitai I, DeAngelo DJ. Wolach O, et al. Among authors: amitai i. Br J Haematol. 2017 Dec;179(5):705-723. doi: 10.1111/bjh.14916. Epub 2017 Oct 26. Br J Haematol. 2017. PMID: 29076138 Free article. Review.

5

PET-adapted therapy for advanced Hodgkin lymphoma - systematic review.

Amitai I, Gurion R, Vidal L, Dann EJ, Raanani P, Gafter-Gvili A. Amitai I, et al. Acta Oncol. 2018 Jun;57(6):765-772. doi: 10.1080/0284186X.2018.1426877. Epub 2018 Jan 18. Acta Oncol. 2018. PMID: 29345517 Review.

6

Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.

Shargian-Alon L, Yahav D, Rozovski U, Dovrat S, Amitai I, Sela-Navon M, Pasvolsky O, Raanani P, Yeshurun M. Shargian-Alon L, et al. Among authors: amitai i. Leuk Lymphoma. 2019 Sep;60(9):2230-2236. doi: 10.1080/10428194.2019.1576869. Epub 2019 Feb 18. Leuk Lymphoma. 2019. PMID: 30773083

7

Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation.

Pasvolsky O, Morelli O, Rozovski U, Vaturi M, Wolach O, Amitai I, Vaxman I, Ratzon R, Yeshurun M, Kornowski R, Iakobishvilli Z, Raanani P. Pasvolsky O, et al. Among authors: amitai i. Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e343-e348. doi: 10.1016/j.clml.2019.03.007. Epub 2019 Mar 11. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30948329

8

Changes in primary outcome and sample size measures after initiation of accrual among trials supporting approval of drugs for hematological malignancies by the US food and drug administration.

Amitai I, Raanani P, Shepshelovich D. Amitai I, et al. Leuk Lymphoma. 2020 Sep;61(9):2216-2220. doi: 10.1080/10428194.2020.1765234. Epub 2020 May 23. Leuk Lymphoma. 2020. PMID: 32449397

9

Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies.

Amitai I, Rozovski U, El-Saleh R, Shimony S, Shepshelovich D, Rozen-Zvi B, Raanani P, Gafter-Gvili A, Gurion R. Amitai I, et al. Hematol Oncol. 2020 Oct;38(4):584-588. doi: 10.1002/hon.2759. Epub 2020 Jun 24. Hematol Oncol. 2020. PMID: 32506594 Clinical Trial.

10

Chronic myeloid leukemia in solid organ transplant patients: a case series.

Amitai I, Abulafia AS, Raanani P, Lipton JH. Amitai I, et al. Int J Hematol. 2021 Feb;113(2):214-218. doi: 10.1007/s12185-020-03014-5. Epub 2020 Oct 6. Int J Hematol. 2021. PMID: 33021721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters